These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 20620413

  • 1. The economic burden of prostate cancer survivorship care.
    Skolarus TA, Zhang Y, Miller DC, Wei JT, Hollenbeck BK.
    J Urol; 2010 Aug; 184(2):532-8. PubMed ID: 20620413
    [Abstract] [Full Text] [Related]

  • 2. Cost of care for elderly cancer patients in the United States.
    Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, Brown ML.
    J Natl Cancer Inst; 2008 May 07; 100(9):630-41. PubMed ID: 18445825
    [Abstract] [Full Text] [Related]

  • 3. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR.
    Cancer; 2007 Feb 01; 109(3):518-27. PubMed ID: 17186528
    [Abstract] [Full Text] [Related]

  • 4. Prostate cancer.
    Penson DF, Chan JM, Urologic Diseases in America Project.
    J Urol; 2007 Jun 01; 177(6):2020-9. PubMed ID: 17509282
    [Abstract] [Full Text] [Related]

  • 5. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications.
    Krupski TL, Foley KA, Baser O, Long S, Macarios D, Litwin MS.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1423-8. PubMed ID: 17706711
    [Abstract] [Full Text] [Related]

  • 6. The economic burden of prostate cancer, California, 1998.
    Max W, Rice DP, Sung HY, Michel M, Breuer W, Zhang X.
    Cancer; 2002 Jun 01; 94(11):2906-13. PubMed ID: 12115378
    [Abstract] [Full Text] [Related]

  • 7. A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer.
    Crawford ED, Black L, Eaddy M, Kruep EJ.
    Prostate Cancer Prostatic Dis; 2010 Jun 01; 13(2):162-7. PubMed ID: 20125121
    [Abstract] [Full Text] [Related]

  • 8. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N, Lubeck DP, Pasta DJ, Latini DM, DuChane J, Carroll PR.
    BJU Int; 2008 Mar 01; 101(6):691-7. PubMed ID: 18291018
    [Abstract] [Full Text] [Related]

  • 9. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M, Walker-Corkery E, Barry MJ.
    J Natl Cancer Inst Monogr; 2004 Mar 01; (33):78-101. PubMed ID: 15504921
    [Abstract] [Full Text] [Related]

  • 10. Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years.
    Pollack LA, Adamache W, Ryerson AB, Eheman CR, Richardson LC.
    Cancer; 2009 Nov 15; 115(22):5284-95. PubMed ID: 19685532
    [Abstract] [Full Text] [Related]

  • 11. Patient time costs associated with cancer care.
    Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, Warren JL.
    J Natl Cancer Inst; 2007 Jan 03; 99(1):14-23. PubMed ID: 17202109
    [Abstract] [Full Text] [Related]

  • 12. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators.
    Prostate Cancer Prostatic Dis; 2008 Jan 03; 11(3):280-7. PubMed ID: 17893700
    [Abstract] [Full Text] [Related]

  • 13. Understanding prostate cancer spending growth among Medicare beneficiaries.
    Zhang Y, Skolarus TA, Miller DC, Wei JT, Hollenbeck BK.
    Urology; 2011 Feb 03; 77(2):326-31. PubMed ID: 21168902
    [Abstract] [Full Text] [Related]

  • 14. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B, Shaffer TJ, Simoni-Wastila LJ, Zuckerman IH, Quinn CC.
    Am J Geriatr Pharmacother; 2007 Sep 03; 5(3):195-208. PubMed ID: 17996659
    [Abstract] [Full Text] [Related]

  • 15. Regional differences in early stage bladder cancer care and outcomes.
    Skolarus TA, Ye Z, Zhang S, Hollenbeck BK.
    Urology; 2010 Aug 03; 76(2):391-6. PubMed ID: 20394976
    [Abstract] [Full Text] [Related]

  • 16. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
    Sennfält K, Carlsson P, Thorfinn J, Frisk J, Henriksson M, Varenhorst E.
    Scand J Urol Nephrol; 2003 Aug 03; 37(3):226-31. PubMed ID: 12775282
    [Abstract] [Full Text] [Related]

  • 17. The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
    Grover SA, Coupal L, Zowall H, Rajan R, Trachtenberg J, Elhilali M, Chetner M, Goldenberg L.
    CMAJ; 2000 Apr 04; 162(7):977-83. PubMed ID: 10763395
    [Abstract] [Full Text] [Related]

  • 18. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF, Warren JL, Potosky AL, Klabunde CN, Harlan LC, Osswald MB.
    Med Care; 2008 Oct 04; 46(10):1108-15. PubMed ID: 18815533
    [Abstract] [Full Text] [Related]

  • 19. Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data.
    Stokes ME, Black L, Benedict A, Roehrborn CG, Albertsen P.
    Prostate Cancer Prostatic Dis; 2010 Sep 04; 13(3):278-84. PubMed ID: 20212521
    [Abstract] [Full Text] [Related]

  • 20. The economic burden of prostate cancer.
    Roehrborn CG, Black LK.
    BJU Int; 2011 Sep 04; 108(6):806-13. PubMed ID: 21884356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.